Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Koenig

Showing results (1-10 of 710) with videos related to

Pageof 71
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2003
C-reactive protein and cardiovascular risk: an update on what is going on in cardiologyWolfgang Koenig
European Cardiology|November 13, 2018
Inflammation Revisited: Atherosclerosis in The Post-CANTOS EraWolfgang Koenig
International Journal of Cardiology|February 3, 2005
Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive proteinWolfgang Koenig
Nature Clinical Practice. Cardiovascular Medicine|January 25, 2007
Is elevated cystatin C a predictor of cardiovascular risk in elderly people without chronic kidney disease?Wolfgang Koenig
Annals of Medicine|March 18, 2009
Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosisWolfgang Koenig
Clinical Chemistry|December 17, 2008
Is hsCRP Back on Board? Implications from the JUPITER TrialWolfgang Koenig
International Journal of Clinical Practice. Supplement|December 3, 2003
Global cardiovascular risk assessment: improving strategies in patients at intermediate riskWolfgang Koenig
International Journal of Cardiology|August 28, 2013
High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapyWolfgang Koenig
JAMA|July 21, 2005
Biomarkers for mortality and cardiovascular eventsWolfgang Koenig
Clinical Chemistry|September 22, 2017
C-Reactive Protein and Cardiovascular Risk: Will the Controversy End after CANTOS?Wolfgang Koenig
Pageof 71

Showing results (1-10 of 710) with videos related to

Sort By:
Pageof 71
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2003
C-reactive protein and cardiovascular risk: an update on what is going on in cardiologyWolfgang Koenig
European Cardiology|November 13, 2018
Inflammation Revisited: Atherosclerosis in The Post-CANTOS EraWolfgang Koenig
International Journal of Cardiology|February 3, 2005
Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive proteinWolfgang Koenig
Nature Clinical Practice. Cardiovascular Medicine|January 25, 2007
Is elevated cystatin C a predictor of cardiovascular risk in elderly people without chronic kidney disease?Wolfgang Koenig
Annals of Medicine|March 18, 2009
Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosisWolfgang Koenig
Clinical Chemistry|December 17, 2008
Is hsCRP Back on Board? Implications from the JUPITER TrialWolfgang Koenig
International Journal of Clinical Practice. Supplement|December 3, 2003
Global cardiovascular risk assessment: improving strategies in patients at intermediate riskWolfgang Koenig
International Journal of Cardiology|August 28, 2013
High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapyWolfgang Koenig
JAMA|July 21, 2005
Biomarkers for mortality and cardiovascular eventsWolfgang Koenig
Clinical Chemistry|September 22, 2017
C-Reactive Protein and Cardiovascular Risk: Will the Controversy End after CANTOS?Wolfgang Koenig
Pageof 71